Long term neuropsychological outcome after head injury: relation to APOE genotype

Millar K; Nicoll J A R; Thornhill S; Murray G D; Teasdale G M; Millar, K; Nicoll, J A R; Thornhill, S; Murray, G D; Teasdale, G M
August 2003
Journal of Neurology, Neurosurgery & Psychiatry;Aug2003, Vol. 74 Issue 8, p1047
Academic Journal
journal article
Background: Existing evidence suggests that some patients who sustain a head injury suffer cognitive decline many years later, and that head injury and possession of the APOE epsilon 4 allele are each risk factors for Alzheimer's disease.Objective: To determine whether late cognitive decline after head injury is more prevalent among carriers of APOE epsilon 4.Methods: A database of head injured patients was used. Initial assessment was at the time of their injury, between 1968 and 1985, and outcome data at six months were available. Their ages at the time of injury ranged between 2 and 70 years. A cohort of 396 subjects was reassessed at a mean of 18 years later, with determination of APOE genotype and detailed neuropsychological testing.Results: Judging by the Glasgow outcome scale, twice as many patients had deteriorated as improved between six months after injury and the late assessment; 22.2% of APOE epsilon 4 carriers had a good late outcome compared with 30.5% of non-carriers (95% confidence interval for the difference, -0.7% to 17.2%; p = 0.084). There were no clear differences between epsilon 4 carriers and non-carriers in detailed neuropsychological assessments.Conclusions: Although this study provides additional evidence that a late decline may occur after head injury, there was no clear relation to APOE genotype. Despite the follow up interval of 15 to 25 years, the cohort is still too young (mean age 42.1 years) to assess the risk of Alzheimer's disease.


Related Articles

  • Alzheimer's first blow. Sobel, Rachel K. // U.S. News & World Report;11/06/2000, Vol. 129 Issue 18, p54 

    Focuses on research linking some cases of Alzheimer's disease and severe head injuries. Analysis of military medical records from World War II veterans by Duke University and National Institutes of Health researchers; Details of a study by Brenda Plassman and colleagues published in 'Neurology.'

  • Acute and chronically increased immunoreactivity to phosphorylation-independent but not pathological TDP-43 after a single traumatic brain injury in humans. Johnson, Victoria; Stewart, William; Trojanowski, John; Smith, Douglas // Acta Neuropathologica;Dec2011, Vol. 122 Issue 6, p715 

    The pathologic phosphorylation and sub-cellular translocation of neuronal transactive response-DNA binding protein (TDP-43) was identified as the major disease protein in frontotemporal lobar degeneration (FTLD) with ubiquitinated inclusions, now termed FTLD-TDP, and amyotrophic lateral...

  • Headbangers Ball: Winter Sports Edition. Long, Frank // Physical Therapy Products;Jan2012, Vol. 23 Issue 1, p6 

    The article focuses on chronic traumatic encephalopathy (CTE), which was described by the "New York Times" as a disease that is closely related to Alzheimers' disease. CTE is caused by repeated blows to the head and its symptoms include dementia, depression and substance abuse. Based on the...

  • Study Links Head Injury with Alzheimer's Disease.  // Nutrition Health Review: The Consumer's Medical Journal;2001, Issue 81, p17 

    Focuses on the links of Alzheimer's disease to serious head injury in the U.S. Development of dementia; Involvement on the loss of consciousness; Demonstration of direct cause-and-effect relationship.

  • Basic facts about Alzheimer's disease.  // Brown University Long-Term Care Quality Advisor;Jan1999, Vol. 11 Issue 1, p1 

    Presents basic facts about Alzheimer's disease, a chronic degenerative and irreversible brain disease characterized by progressive loss of cognitive function, impaired memory, thinking and behavior and increasing dependency on others for day-to-day care. Symptoms of the disease; Duration of...

  • Progress Report on Alzheimer's Disease: Taking the Next Steps.  // Ageing International;Summer/Fall2000, Vol. 26 Issue 1/2, p38 

    Provides information on Alzheimer's disease (AD), an age-related and irreversible brain disorder that occurs gradually and results in memory loss, behavior and personality changes and a decline in thinking abilities. Impact of AD; Main characteristics of AD; Causes of AD; Genetic factors in AD...

  • What you need to know about Alzheimer's disease.  // South Asian Post;2/7/2013, p6 

    The article offers information on Alzheimer's disease and says that initiation of brain disorders should not be taken easily.

  • From the editor. Stevens, Celia // MLO: Medical Laboratory Observer;Nov2002, Vol. 34 Issue 11, p4 

    Focuses on the Alzheimer's Disease experienced by author's grandmother. Nature of author's grandmother; Diagnosis of the disease; Development in the areas of screening the disease.

  • Targeting Alzheimer amyloid plaques in vivo. Wengenack, Thomas M.; Curran, Geoffry L.; Poduslo, Joseph F. // Nature Biotechnology;Aug2000, Vol. 18 Issue 8, p868 

    The only definitive diagnosis for Alzheimer disease (AD) at present is postmortem observation of neuritic plaques and neurofibrillary tangles in brain sections. Radiolabeled amyloid-β peptide (Aβ), which has been shown to label neuritic plaques in vitro, therefore could provide a...


Read the Article


Sign out of this library

Other Topics